HBK Sorce Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
1,796
+49
+3% +$10.2K 0.01% 417
2026
Q1
$321K Buy
1,747
+13
+0.7% +$2.8K 0.01% 481
2025
Q4
$392K Sell
1,734
-105
-6% -$19.8K 0.01% 421
2025
Q3
$286K Sell
1,839
-19
-1% -$2.94K 0.01% 486
2025
Q2
$312K Buy
1,858
+41
+2% +$6.08K 0.01% 451
2025
Q1
$250K Buy
+1,817
New +$232K 0.01% 491

Other funds holding CAH

HBK Sorce Advisory's CAH Position: Q2 2026 in Review

HBK Sorce Advisory increased its Cardinal Health (CAH) stake by 2.8% in Q2 2026, buying an estimated $10.2K and bringing the position to 1,796 shares worth $430K. The position accounts for 0.01% of the portfolio, ranked #417.

HBK Sorce Advisory first reported a position in CAH in Q1 2025 and has held it in 6 quarters since. 857 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • HBK Sorce Advisory held 1,796 shares of Cardinal Health worth $430K as of Q2 2026.
  • HBK Sorce Advisory bought 49 Cardinal Health shares in Q2 2026, an estimated $10.2K.
  • Cardinal Health made up 0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #417 holding.
  • HBK Sorce Advisory first reported a position in Cardinal Health in Q1 2025 and has held it in 6 quarters since.
  • 857 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.